Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63 | 54 | -2,620 | -1,403 | -1,047 |
| Depreciation Amortization | 57 | 29 | 601 | 490 | 317 |
| Accounts receivable | N/A | N/A | 8 | 9 | 7 |
| Accounts payable and accrued liabilities | -13 | 1 | -139 | -61 | 23 |
| Other Working Capital | 202 | 105 | 14 | -93 | -155 |
| Other Operating Activity | -248 | -261 | 1,850 | 760 | 526 |
| Operating Cash Flow | $-65 | $-73 | $-286 | $-298 | $-328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -3 | -1 | N/A |
| Net Acquisitions | 100 | 100 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -6 | -6 | -6 |
| Other Investing Activity | 0 | 0 | -6 | -6 | -6 |
| Investing Cash Flow | $100 | $100 | $-9 | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 405 | 405 | 399 |
| Other Financing Activity | -33 | -33 | -113 | -102 | -65 |
| Financing Cash Flow | $-33 | $-33 | $293 | $303 | $334 |
| Beginning Cash Position | 8 | 8 | 10 | 10 | 10 |
| End Cash Position | 9 | 1 | 8 | 8 | 9 |
| Net Cash Flow | $2 | $-6 | $-2 | $-2 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65 | -73 | -286 | -298 | -328 |
| Capital Expenditure | N/A | N/A | -3 | -1 | N/A |
| Free Cash Flow | -65 | -73 | -289 | -299 | -328 |